
Keywords: drug-related side effects and adverse reactions; angiomyolipoma; sirolimus; therapeuticsITT, intent to treat; LD, longest diameter; mTOR, mammalian target of rapamycin; PP, per protocol; RCT, randomized controlled trial; SAE, serious adverse event; sLAM,